-
Allarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors
26 Sep 2022 10:00 GMT
… biotechnology executive with extensive experience in financing, drug … leadership roles at NuPathe, Inc., Endo Pharmaceuticals Inc., and … -license to Smerud Medical Research International AS; … clinical outcome from drug treatment in cancer patients …
-
Allarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors
26 Sep 2022 12:32 GMT
… biotechnology executive with extensive experience in financing, drug … leadership roles at NuPathe, Inc., Endo Pharmaceuticals Inc., and … -license to Smerud Medical Research International AS; … clinical outcome from drug treatment in cancer patients …
-
The Global Transdermal Patch Market is Expected to Reach $20 Billion by 2028 - ResearchAndMarkets.com
16 Mar 2022 15:53 GMT
… new drug application for Aldarity (donepezil transdermal system) for the treatment … for pharmaceutical companies. Several ongoing clinical trials are evaluating novel vaccine patch for … NeurogesX
16.23 Noven Pharmaceuticals
16.24 NuPathe
16.25 Nuvo …
-
Diffusion Pharmaceuticals Appoints Jane H. Hollingsworth to its Board of Directors
01 Sep 2020 20:02 GMT
… NuPathe … Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc. is an innovative biotechnology company developing new treatments … treatment of life-threatening medical conditions. Diffusion’s lead drug … FDA has not approved a trial evaluating TSC for the treatment …
-
Transdermal Patch Market Study 2020-2026 - Global Market Projected to Surpass $15 Billion by 2026
17 Jan 2020 14:18 GMT
… patches in existing drug delivery methodology available to pharmaceutical … Patches
Global Transdermal Patch Clinical Trials Insight by Company, Drug … drug delivery methodologies like pill, powder, or liquid medication … 22 Noven Pharmaceuticals
15.23 NuPathe
15. …
-
Zynerba Pharmaceuticals to Present at FDA’s Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-derived Compounds
30 May 2019 20:30 GMT
… S. Food and Drug Administration’s (FDA) Public Hearing … engineering experience in the pharmaceutical, medical devices and electrical … the Zecuity® migraine patch while also managing all … of increasing responsibility at NuPathe, Puricore, Kensey Nash …
-
Zosano: From Phase 3 To Approval Of A Best-In-Class Migraine Treatment
22 May 2019 14:00 GMT
… address the large molecule, vaccine, biosimilar markets. Cantor Fitzgerald … TEVA) acquired NuPathe for $144M for its migraine patch Zecuity which … had a new drug approved for treatment in the last … future royalties. Many small biotechs give into small future …
-
Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2025 - Focus on Marketed, Clinical and Preclinical Products / Product Candidates for Management of Chronic Pain
25 Sep 2018 08:05 GMT
… that are used for the treatment /; management of pain … : Fasinumab
7.9. Drug Profile: Fremanezumab
7.10. Drug Profile: Galcanezumab … Medical
Optinose
Orbimed Advisors
Osage University
Oska Wellness
Otsuka Pharmaceutical
PainPod BioTechnology
…
-
Drug Delivery Technologies Market Forecast 2018-2028
05 Feb 2018 14:42 GMT
… Drug Delivery Technologies; Forecasts for Biologics, Vaccines … more patient-friendly treatments in healthcare.
… Pharmaceuticals
CRISI Medical Systems
CTCBIO
Daiichi
Elan Drug Technologies
Elcam Medical … NuPathe
NV NOM
Oramed
OwenMumford
Pacira Pharmaceuticals …
About
© 1995-2025